Ronald Scheff

Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial

Nasser K. Altorki, Timothy E. McGraw, Alain Borczuk et al. · The Lancet Oncology · 2021 · 330 citations

Medicine, Oncology, Radiation Oncology +14

Therapy of Advanced Non–Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan

Rebecca S. Heist, Michael J. Guarino, Gregory A. Masters et al. · Journal of Clinical Oncology · 2017 · 190 citations

Medicine, Oncology, Pharmacology +15

Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma

John A. Boockvar, Apostolos John Tsiouris, Christoph P. Hofstetter et al. · Journal of neurosurgery · 2010 · 164 citations · Full text

Medicine, Neurosurgery, Oncology +13

Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I–inhibiting Antibody–Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan

Jhanelle E. Gray, Rebecca S. Heist, Alexander Starodub et al. · Clinical Cancer Research · 2017 · 159 citations · Full text

Medicine, Oncology, Pharmacology +17

Employment After a Breast Cancer Diagnosis: A Qualitative Study of Ethnically Diverse Urban Women

Victoria Blinder, Madhuvanti M. Murphy, Linda T. Vahdat et al. · Journal of Community Health · 2011 · 79 citations

Medicine, Oncology, Urban Health +13